Examkin

Question

Difficulty: HardDepressive Disorders

A 34-year-old woman presents to the clinic with a 6-week history of profound sadness, anhedonia, and terminal insomnia. She reports significant functional impairment, having recently taken a leave of absence from her job due to a severe inability to concentrate. Review of systems is notable for a 4.5-kg (10-lb) weight loss and mild psychomotor agitation. Thorough psychiatric screening confirms the absence of any past manic or hypomanic episodes, ruling out bipolar disorder. Over the next 14 months, her major depressive disorder exhibits a complex trajectory, requiring a progressive, stepped-care escalation of her management plan according to standard psychiatric guidelines. Arrange the following clinical interventions in the most appropriate chronological sequence, beginning with her initial presentation and escalating to the management of life-threatening psychiatric complications.

  1. 1Initiate pharmacotherapy with a first-line selective serotonin reuptake inhibitor (e.g., sertraline) alongside psychoeducation.
  2. 2Titrate the initial selective serotonin reuptake inhibitor (SSRI) to its maximum tolerated therapeutic dose due to an inadequate clinical response at 6 weeks.
  3. 3Cross-titrate to an antidepressant with a different mechanism of action (e.g., a serotonin-norepinephrine reuptake inhibitor) after a complete lack of response to an optimized medication trial.
  4. 4Augment the current regimen with a second-generation antipsychotic (e.g., aripiprazole) or lithium to address a partial response to therapy.
  5. 5Proceed with electroconvulsive therapy (ECT) following the acute onset of food refusal, severe psychomotor retardation, and active suicidal intent with a specific plan.

Answer

The correct chronological sequence of management is: (1) Initiate a first-line SSRI, (2) Titrate the SSRI to the maximum dose for inadequate response, (3) Switch to a different antidepressant class for complete non-response, (4) Augment with a second-generation antipsychotic for partial response, and (5) Proceed with ECT for life-threatening complications.
The standard stepped-care algorithm for major depressive disorder prioritizes single-agent optimization before increasing complexity. Treatment begins with initiating a first-line agent, such as an SSRI. If the initial dose yields inadequate results after an appropriate timeframe (4-6 weeks), the dose must be optimized to the maximum tolerated level. If there is a complete lack of response to the optimized dose, switching to a different class (e.g., SNRI) is indicated to target different neurotransmitters. If a subsequent trial results in a partial response, augmenting with a second agent (e.g., aripiprazole, lithium) is preferred to build on the existing improvement. Finally, if the depression becomes completely treatment-resistant and progresses to life-threatening symptoms (such as active suicidality or food refusal), electroconvulsive therapy (ECT) becomes the urgent intervention of choice.

Step-by-Step Solution

1
Initiate pharmacotherapy with a first-line SSRI.
Establishes baseline pharmacotherapy for the acute depressive episode.
SSRIs are the first-line standard of care for uncomplicated major depressive disorder after ruling out bipolar disorder.
2
Titrate the initial SSRI to the maximum tolerated dose.
Achieves the maximum potential therapeutic effect of the initial agent.
Premature discontinuation is a common error; a trial must be optimized to maximum tolerated doses for at least 4-6 weeks before being declared a failure.
3
Cross-titrate to an antidepressant with a different mechanism of action (e.g., SNRI).
Switches the neurochemical target to overcome complete non-response.
Switching classes is preferred over augmentation when there is a complete lack of response to an optimized initial monotherapy trial.
4
Augment the second antidepressant with a second-generation antipsychotic.
Builds upon the partial clinical improvement achieved by the second agent.
Augmentation is the preferred evidence-based strategy when the current agent provides partial efficacy, avoiding the loss of partial gains that might occur with another switch.
5
Proceed with electroconvulsive therapy (ECT).
Provides definitive, rapid symptom relief for treatment-resistant depression.
ECT becomes necessary and life-saving when treatment-resistant depression progresses to include emergent complications like food refusal, catatonia, or active suicidality.

Key Concept

Stepped-care treatment escalation for major depressive disorder.
Rate this question

Topics

Depressive Disorders

More questions from this topic